AI in Cancer Detection has 560 eligible papers in the latest 30-day evidence window, roughly steady against the prior window, with representative work spanning Multi-modal AI for comprehensive breast cancer prognostication; Benchmarking Pathology Foundation Models for Breast Cancer Survival Prediction; Explainable artificial intelligence with pyramid vision transformer model for multi-class malignant cell classification on cytology slides.
AI in Cancer Detection shows 560 eligible recent papers and 558 commentary-ready papers in the current 30-day window, compared with 546 eligible papers in the prior window. The strongest evidence comes from 1 visible topic cluster and 8 representative papers. Several representative papers may be preprints, so this brief treats them as emerging signals rather than settled consensus.
AI in Cancer Detection recorded 560 eligible papers in the latest 30-day window, compared with 546 in the prior 30-day window, making the current snapshot roughly steady against the prior window.
560 recent vs 546 prior eligible papersAI in cancer detection contributes 560 eligible recent papers, including 558 papers with abstracts available for commentary.
560 papers in the leading clusterThe representative set includes Multi-modal AI for comprehensive breast cancer prognostication; Benchmarking Pathology Foundation Models for Breast Cancer Survival Prediction; Explainable artificial intelligence with pyramid vision transformer model for multi-class malignant cell classification on cytology slides; Examination of Pathologist–Artificial Intelligence Interactions and Their Impact on Pathologist Accuracy Using Artificial Intelligence–Assisted Scoring of Immunohistochemistry for Human Epidermal Growth Factor Receptor 2; and other recent papers. These papers anchor the page's claims and keep the brief tied to visible evidence.
8 representative papersAI in cancer detection accounts for 560 eligible recent papers, including 558 commentary-ready papers in this evidence window.
560 recent eligible papersThe selected papers cover Multi-modal AI for comprehensive breast cancer prognostication; Benchmarking Pathology Foundation Models for Breast Cancer Survival Prediction; Explainable artificial intelligence with pyramid vision transformer model for multi-class malignant cell classification on cytology slides; Examination of Pathologist–Artificial Intelligence Interactions and Their Impact on Pathologist Accuracy Using Artificial Intelligence–Assisted Scoring of Immunohistochemistry for Human Epidermal Growth Factor Receptor 2. 3 of the representative papers are marked as preprints, so their findings should be treated cautiously.
8 representative papersA preprint from Nature Communications in the AI in cancer detection evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A preprint from arXiv (Cornell University) in the AI in cancer detection evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Scientific Reports in the AI in cancer detection evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Archives of Pathology & Laboratory Medicine in the AI in cancer detection evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A preprint from arXiv (Cornell University) in the AI in cancer detection evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Bioengineering in the AI in cancer detection evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Frontiers in Bioinformatics in the AI in cancer detection evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.
A recent paper from Scientific Reports in the AI in cancer detection evidence packet, selected because it is recent, abstract-backed, and representative of this week's topic activity.